These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33870067)

  • 1. Epistemic Corruption, the Pharmaceutical Industry, and the Body of Medical Science.
    Sismondo S
    Front Res Metr Anal; 2021; 6():614013. PubMed ID: 33870067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials and the origins of pharmaceutical fraud: Parke, Davis & Company, virtue epistemology, and the history of the fundamental antagonism.
    Gabriel JM; Holman B
    Hist Sci; 2020 Dec; 58(4):533-558. PubMed ID: 32713203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction: Institutional corruption and the pharmaceutical policy.
    Rodwin MA
    J Law Med Ethics; 2013; 41(3):544-52. PubMed ID: 24088143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting opioids, a story about how to influence medical science and opinions.
    Bernisson M; Sismondo S
    Front Med (Lausanne); 2024; 11():1327939. PubMed ID: 38737766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conflicts of interest in research involving human beings.
    Greco D; Diniz NM
    J Int Bioethique; 2008; 19(1-2):143-54, 202-3. PubMed ID: 18664007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key opinion leaders and the corruption of medical knowledge: what the Sunshine Act will and won't cast light on.
    Sismondo S
    J Law Med Ethics; 2013; 41(3):635-43. PubMed ID: 24088154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sponsorship, conflict of interest and corruption: promoting science in discussion of medical ethics].
    Frewer A
    Wien Med Wochenschr; 2002; 152(9-10):234-7. PubMed ID: 12094397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug firms, the codification of diagnostic categories, and bias in clinical guidelines.
    Cosgrove L; Wheeler EE
    J Law Med Ethics; 2013; 41(3):644-53. PubMed ID: 24088155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conflicts of Interest in Medicine. A Systematic Review of Published and Scientifically evaluated Curricula.
    Weißkircher J; Koch C; Dreimüller N; Lieb K
    GMS J Med Educ; 2017; 34(3):Doc37. PubMed ID: 28890928
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulating for Bias in Medical Education - Reaction to the Pharmaceutical Industry Updated EFPIA Code of Practice.
    Rodzinka M; Seebohm A; Pozniak E; Mosch L; De Luca L; McArdle J; Griebenow R; Velcheva M
    J Eur CME; 2019; 8(1):1685771. PubMed ID: 31807368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Archeology of Corruption in Medicine.
    Little M; Lipworth W; Kerridge I
    Camb Q Healthc Ethics; 2018 Jul; 27(3):525-535. PubMed ID: 29845925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improper healthcare marketing: German and Ukrainian experience in prevention.
    Gutorova N; Soloviov O; Olejnik D
    Wiad Lek; 2019; 72(12 cz 2):2404-2409. PubMed ID: 32124760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of corruption and unethical behaviour in precluding the placement of industry sponsored clinical trials in sub-Saharan Africa: Stakeholder views.
    Egharevba E; Atkinson J
    Contemp Clin Trials Commun; 2016 Aug; 3():102-110. PubMed ID: 29736462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scientism, conflicts of interest, and the marginalization of ethics in medical education.
    Mayes C; Williams J; Kerridge I; Lipworth W
    J Eval Clin Pract; 2018 Oct; 24(5):939-944. PubMed ID: 29105237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tackling corruption in the pharmaceutical systems worldwide with courage and conviction.
    Cohen JC; Mrazek M; Hawkins L
    Clin Pharmacol Ther; 2007 Mar; 81(3):445-9. PubMed ID: 17251983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CORRUPTION OFFENCES IN MEDICATIONS CIRCULATION: INVESTIGATION PROBLEMS.
    Latysh KV; Demidova YE
    Wiad Lek; 2021; 74(11 cz 2):2896-2900. PubMed ID: 35029552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Archeology of Corruption in Medicine.
    Little M; Lipworth W; Kerridge I
    J Bioeth Inq; 2022 Mar; 19(1):109-116. PubMed ID: 35362930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conflicts of interest, institutional corruption, and pharma: an agenda for reform.
    Rodwin MA
    J Law Med Ethics; 2012; 40(3):511-22. PubMed ID: 23061578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epistemic interests and the objectivity of inquiry.
    Wilholt T
    Stud Hist Philos Sci; 2022 Feb; 91():86-93. PubMed ID: 34891050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.